The U.S. Food and Drug Administration has approved Eli Lilly's Omvoh (mirikizumab-mrkz) for the treatment of moderately to severely active Crohn's disease in adults.
Jan 17, 2025
0
17
Results of a Phase III study conducted by an international team of researchers reveal that mirikizumab is more effective and has a favorable safety profile with fewer serious adverse events compared to a placebo for individuals ...
The U.S. Food and Drug Administration (FDA) approved mirikizumab, on October 26, 2023, a highly effective new treatment for ulcerative colitis (UC), offering a new option to patients battling this chronic and debilitating ...
Oct 30, 2023
0
49
A new drug, investigated by Amsterdam University Medical Centers together with colleagues around the world, is effective as a treatment against ulcerative colitis. With the clinical trial demonstrating a doubling in the rates ...
Jun 28, 2023
0
96
